| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Clinical and Laboratory Medicine, Akita University School of Medicine, Akita, Japan; and
Department of Internal Medicine, Division of Allergy and Immunology, University of Texas Medical Branch, Galveston, TX 77555
The CC chemokine eotaxin plays a pivotal role in local accumulation of eosinophils. Very little is known about the eotaxin signaling in eosinophils except the activation of the mitogen-activated protein (MAP) kinase family. The p21 G protein Rho and its substrate Rho-associated coiled-coil forming protein kinase (ROCK) regulate the formation of stress fibers and focal adhesions. In the present study, we studied the functional relevance of Rho and ROCK in eosinophils using the ROCK inhibitor (Y-27632) and exoenzyme C3, a specific Rho inhibitor. Eotaxin stimulates activation of Rho A and ROCK II in eosinophils. Exoenzyme C3 almost completely inhibited the ROCK activity, indicating that ROCK is downstream of Rho. We then examined the role of Rho and ROCK in eosinophil chemotaxis. The eotaxin-induced eosinophil chemotaxis was significantly inhibited by exoenzyme C3 or Y-27632. Because extracellular signal-regulated kinase (ERK)1/2 and p38 MAP kinases are activated by eotaxin and are critical for eosinophil chemotaxis, we investigated whether Rho and ROCK are upstream of these MAP kinases. C3 partially inhibited eotaxin-induced phosphorylation of ERK1/2 but not p38. In contrast, neither ERK1/2 nor p38 phosphorylation was abrogated by Y-27632. Both C3 and Y-27632 reduced reactive oxygen species production from eosinophils. We conclude that both Rho and ROCK are important for eosinophil chemotaxis and reactive oxygen species production. There is a dichotomy of downstream signaling pathways of Rho, namely, Rho-ROCK and Rho-ERK pathways. Taken together, eosinophil chemotaxis is regulated by multiple signaling pathways that involve at least ROCK, ERK, and p38 MAP kinase.
This article has been cited by other articles:
|
|
 |
|
  A. A. Zeki, L. Franzi, J. Last, and N. J. Kenyon Simvastatin Inhibits Airway Hyperreactivity: Implications for the Mevalonate Pathway and Beyond Am. J. Respir. Crit. Care Med., October 15, 2009; 180(8): 731 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Schaafsma, I. S. T. Bos, A. B. Zuidhof, J. Zaagsma, and H. Meurs The inhaled Rho kinase inhibitor Y-27632 protects against allergen-induced acute bronchoconstriction, airway hyperresponsiveness, and inflammation Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L214 - L219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Muessel, K. S. Scott, P. Friedl, P. Bradding, and A. J. Wardlaw CCL11 and GM-CSF Differentially Use the Rho GTPase Pathway to Regulate Motility of Human Eosinophils in a Three-Dimensional Microenvironment J. Immunol., June 15, 2008; 180(12): 8354 - 8360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Adachi, S. Hanaka, T. Masuda, H. Yoshihara, H. Nagase, and K. Ohta Transduction of Phosphatase and Tensin Homolog Deleted on Chromosome 10 into Eosinophils Attenuates Survival, Chemotaxis, and Airway Inflammation J. Immunol., December 15, 2007; 179(12): 8105 - 8111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Fernandes, P. J. Henry, and R. G. Goldie Review: Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 25 - 33. [Abstract] [PDF]
|
|
|
|
|
|
Y. Kobayashi, S. Ueki, G. Mahemuti, T. Chiba, H. Oyamada, N. Saito, A. Kanda, H. Kayaba, and J. Chihara Physiological Levels of 15-Deoxy-{Delta}12,14-Prostaglandin J2 Prime Eotaxin-Induced Chemotaxis on Human Eosinophils through Peroxisome Proliferator-Activated Receptor-{gamma} Ligation J. Immunol., November 1, 2005; 175(9): 5744 - 5750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Iijima, Y. Yanagawa, J. M. Clingan, and K. Onoe CCR7-mediated c-Jun N-terminal kinase activation regulates cell migration in mature dendritic cells Int. Immunol., September 1, 2005; 17(9): 1201 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Joubert, S. Lajoie-Kadoch, I. Labonte, A. S. Gounni, K. Maghni, V. Wellemans, J. Chakir, M. Laviolette, Q. Hamid, and B. Lamkhioued CCR3 Expression and Function in Asthmatic Airway Smooth Muscle Cells J. Immunol., August 15, 2005; 175(4): 2702 - 2708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Fulkerson, H. Zhu, D. A. Williams, N. Zimmermann, and M. E. Rothenberg CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism Blood, July 15, 2005; 106(2): 436 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kishimoto, M. Gokoh, S. Oka, M. Muramatsu, T. Kajiwara, K. Waku, and T. Sugiura 2-Arachidonoylglycerol Induces the Migration of HL-60 Cells Differentiated into Macrophage-like Cells and Human Peripheral Blood Monocytes through the Cannabinoid CB2 Receptor-dependent Mechanism J. Biol. Chem., June 27, 2003; 278(27): 24469 - 24475. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
